Evidence map›Paper›PMID 34200924›Full record

ReviewCancers2021

A Comprehensive Review on Solitary Fibrous Tumor: New Insights for New Horizons.

Javier Martin-Broto, Jose L Mondaza-Hernandez, David S Moura, Nadia Hindi

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 2 pooled it
16.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 2 syntheses or guidelines pooled it, 152 citations in OpenAlex.

  1. Spontaneous complete regression of congenital brain tumors - a systematic literature review and case report.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2026
    Pooled it
  2. Guideline
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Systemic Therapy for Solitary Fibrous Tumor.Current treatment options in oncology · 2026
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Javier Martin-BrotoFundacion Jimenez Díaz University Hospital, 28040 Madrid, Spain.ORCID 0000-0001-7350-6916
Jose L Mondaza-HernandezInstitute of Biomedicine of Seville (IBiS, CSIC, US and HUVR), 41013 Sevilla, Spain.ORCID 0000-0002-5642-3796
David S MouraInstitute of Biomedicine of Seville (IBiS, CSIC, US and HUVR), 41013 Sevilla, Spain.ORCID 0000-0002-6514-2419
Nadia HindiFundacion Jimenez Díaz University Hospital, 28040 Madrid, Spain.ORCID 0000-0002-5864-762X
Hospital Universitario Fundación Jiménez Díaz · ESInstituto de Biomedicina de Sevilla · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Solitary fibrous tumor (SFT) is a rare mesenchymal, ubiquitous tumor, with an incidence of 1 new case/million people/year. In the 2020 WHO classification, risk stratification models were recommended as a better tool to determine prognosis in SFT, to the detriment of "typical" or "malignant" classic terms. The risk for metastasis is up to 35-45%, or even greater, in series with a longer follow-up. Over the last few decades, advances in immunohistochemistry and molecular diagnostics identified STAT6 nuclear protein expression and the

Indexed as

anti-angiogenicssolitary fibrous tumortherapytumor biology

Identifiers

PMID34200924
PMCPMC8230482
OpenAlexW3167424644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.